Implantable cardioverter-defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: A role for genotyping in decision-making?

Journal of the American College of Cardiology

Volumn 45, Issue 3, 2005, Pages 409-411

  Wichter, Thomas ^a   Breithardt, Günter ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOSOMAL DOMINANT DISORDER; CARDIOVASCULAR RISK; CHROMOSOME 3P; CHROMOSOME ANALYSIS; CLINICAL OBSERVATION; CORRELATION ANALYSIS; DEFIBRILLATOR; DEVICE; FAMILIAL DISEASE; FOLLOW UP; GENE FUNCTION; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; HAPLOTYPE; HEART RIGHT VENTRICLE DYSPLASIA; HIGH RISK PATIENT; HUMAN; IMPLANTATION; METHODOLOGY; MORTALITY; NOTE; PHENOTYPE; POPULATION RESEARCH; PRIMARY PREVENTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SECONDARY PREVENTION; TREATMENT INDICATION;

EID: 13244292435     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.11.009     Document Type: Editorial

References (10)

1. Hodgkinson KA, Parfrey PS, Bassett AS, et al. The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5). J Am Coll Cardiol 2005;45:400-8.
2. F. Ahmad, D. Li, A. Karibe, O. Gonzalez Localization of a gene responsible for arrhythmogenic right ventricular dysplasia to chromosome 3p23 Circulation 98 1998 2791 2795
3. G. Breithardt, T. Wichter, W. Haverkamp Implantable cardioverter defibrillator therapy in patients with arrhythmogenic right ventricular cardiomyopathy, long QT syndrome, or no structural heart disease Am Heart J 127 1994 1151 1158
4. M.S. Link, P.J. Wang, C.J. Haugh Arrhythmogenic right ventricular dysplasia: clinical results with implantable cardioverter-defibrillators J Intervent Card Electrophysiol 1 1997 41 48
5. R. Tavernier, S. Gevaert, J. De Sutter Long-term results of cardioverter-defibrillator implantation in patients with right ventricular dysplasia and malignant ventricular tachyarrhythmias Heart 85 2001 53 56
6. D. Corrado, L. Leoni, M.S. Link Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia Circulation 108 2003 3084 3091
7. T. Wichter, M. Paul, C. Wollmann Implantable cardioverter-defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients Circulation 109 2004 1503 1508
8. A. Rougin, C.S. Bomma, K. Nasir Implantable cardioverter-defibrillators inpatients with arrhythmogenic right ventricular dysplasia/cardiomyopathy J Am Coll Cardiol 43 2004 1843 1852
9. M. Paul, E. Schulze-Bahr, G. Breithardt, T. Wichter Genetics of arrhythmogenic right ventricular cardiomyopathy--status quo and future perspectives Z Kardiol 92 2003 128 136
10. B. Gerull, A. Heuser, T. Wichter Mutations in the desmosomal arm repeat protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy Nat Genet 36 2004 1162 1164